U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07242807) titled 'Minimally Invasive Prostate Interventions Registry (MIST Study)' on Nov. 17.

Brief Summary: This study is a multicenter prospective patient registry designed to evaluate clinical, functional, and safety outcomes after minimally invasive prostate interventions (MIST) performed for benign prostatic obstruction (BPO) secondary to benign prostatic hyperplasia (BPH). The interventions included in this registry represent standard-of-care treatment options and may include Rezum water vapor therapy, UroLift prostatic urethral lift, Aquablation, prostatic artery embolization (PAE), iTind, transperineal laser ablation (TPLA), transurethral ne...